The importance of NADPH oxidases and redox signaling in angiogenesis

Antioxidants

Volumn 6, Issue 2, 2017, Pages

  Prieto Bermejo, Rodrigo ^a   Hernández Hernández, Angel ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Angiogenesis; NADPH oxidase (Nox); Redox signaling; ROS

Indexed keywords

EID: 85019723234     PISSN: None     EISSN: 20763921     Source Type: Journal    
DOI: 10.3390/antiox6020032     Document Type: Review

References (214)

1. Turrens, J.F.: Mitochondrial Formation of Reactive Oxygen Species. J. Physiol. 2003, 552, 335–344. [CrossRef] [PubMed]
2. Genestra, M. Oxyl Radicals, Redox-Sensitive Signalling Cascades and Antioxidants. Cell Signal. 2007, 19, 1807–1819. [CrossRef] [PubMed]
3. Valko, M., Jomova, K., Rhodes, C.J., Kuca, K., Musilek, K. Redox- and Non-Redox-Metal-Induced Formation of Free Radicals and Their Role in Human Disease. Arch. Toxicol. 2016, 90, 1–37. [CrossRef] [PubMed]
4. Kauppila, T.E., Kauppila, J.H., Larsson, N.G.: Mammalian Mitochondria and Aging: An Update. Cell Metab. 2017, 25, 57–71. [CrossRef] [PubMed]
5. Sardina, J.L., Lopez-Ruano, G., Sanchez-Sanchez, B., Llanillo, M., Hernandez-Hernandez, A. Reactive Oxygen Species: Are They Important for Haematopoiesis? Crit. Rev. Oncol. Hematol. 2012, 81, 257–274. [CrossRef] [PubMed]
6. Galadari, S., Rahman, A., Pallichankandy, S., Thayyullathil, F.: Reactive Oxygen Species and Cancer Paradox: To Promote or to Suppress? Free Radic. Biol. Med. 2017, 104, 144–164. [CrossRef] [PubMed]
7. Tatla, S., Woodhead, V., Foreman, J.C., Chain, B.M. The Role of Reactive Oxygen Species in Triggering Proliferation and IL-2 Secretion in T Cells. Free Radic. Biol. Med. 1999, 26, 14–24. [CrossRef]
8. Goldstone, S.D., Milligan, A.D., Hunt, N.H.: Oxidative Signalling and Gene Expression during Lymphocyte Activation. Biochim. Biophys. Acta 1996, 1314, 175–182. [CrossRef]
9. Czech, M.P.: Differential Effects of Sulfhydryl Reagents on Activation and Deactivation of the Fat Cell Hexose Transport System. J. Biol. Chem. 1976, 251, 1164–1170. [PubMed]
10. Mukherjee, S.P., Lane, R.H., Lynn, W.S. Endogenous Hydrogen Peroxide and Peroxidative Metabolism in Adipocytes in Response to Insulin and Sulfhydryl Reagents. Biochem. Pharmacol. 1978, 27, 2589–2594. [CrossRef]
11. Sies, H.: Hydrogen Peroxide as a Central Redox Signaling Molecule in Physiological Oxidative Stress: Oxidative Eustress. Redox Biol. 2017, 11, 613–619. [CrossRef] [PubMed]
12. Bak, D.W., Weerapana, E. Cysteine-Mediated Redox Signalling in the Mitochondria. Mol. Biosyst. 2015, 11, 678–697. [CrossRef] [PubMed]
13. Manning, G., Whyte, D.B., Martinez, R., Hunter, T., Sudarsanam, S. The Protein Kinase Complement of the Human Genome. Science 2002, 298, 1912–1934. [CrossRef] [PubMed]
14. Sacco, F., Perfetto, L., Castagnoli, L., Cesareni, G. The Human Phosphatase Interactome: An Intricate Family Portrait. FEBS Lett. 2012, 586, 2732–2739. [CrossRef] [PubMed]
15. Shi, Y. Serine/Threonine Phosphatases: Mechanism through Structure. Cell 2009, 139, 468–484. [CrossRef] [PubMed]
16. Alonso, A., Sasin, J., Bottini, N., Friedberg, I., Friedberg, I., Osterman, A., Godzik, A., Hunter, T., Dixon, J., Mustelin, T. Protein Tyrosine Phosphatases in the Human Genome. Cell 2004, 117, 699–711. [CrossRef] [PubMed]
17. Zhang, Z.Y., Wang, Y., Dixon, J.E. Dissecting the Catalytic Mechanism of Protein-Tyrosine Phosphatases. Proc. Natl. Acad. Sci. USA 1994, 91, 1624–1627. [CrossRef] [PubMed]
18. Barford, D., Flint, A.J., Tonks, N.K. Crystal Structure of Human Protein Tyrosine Phosphatase 1B. Science 1994, 263, 1397–1404. [CrossRef] [PubMed]
19. Meng, T.C., Fukada, T., Tonks, N.K.: Reversible Oxidation and Inactivation of Protein Tyrosine Phosphatases in Vivo. Mol. Cell 2002, 9, 387–399. [CrossRef]
20. Zhang, Z.Y., Dixon, J.E. Active Site Labeling of the Yersinia Protein Tyrosine Phosphatase: The Determination of the PKa of the Active Site Cysteine and the Function of the Conserved Histidine 402. Biochemistry 1993, 32, 9340–9345. [CrossRef] [PubMed]
21. Barrett, W.C., DeGnore, J.P., Konig, S., Fales, H.M., Keng, Y.F., Zhang, Z.Y., Yim, M.B., Chock, P.B. Regulation of PTP1B Via Glutathionylation of the Active Site Cysteine 215. Biochemistry 1999, 38, 6699–6705. [CrossRef] [PubMed]
22. Lee, S.R., Kwon, K.S., Kim, S.R., Rhee, S.G. Reversible Inactivation of Protein-Tyrosine Phosphatase 1B in A431 Cells Stimulated With Epidermal Growth Factor. J. Biol. Chem. 1998, 273, 15366–15372. [CrossRef] [PubMed]
23. Kwon, J., Qu, C.K., Maeng, J.S., Falahati, R., Lee, C., Williams, M.S. Receptor-Stimulated Oxidation of SHP-2 Promotes T-Cell Adhesion Through SLP-76-ADAP. EMBO J. 2005, 24, 2331–2341. [CrossRef] [PubMed]
24. Singh, D.K., Kumar, D., Siddiqui, Z., Basu, S.K., Kumar, V., Rao, K.V. The Strength of Receptor Signaling Is Centrally Controlled through a Cooperative Loop between Ca2+ and an Oxidant Signal. Cell 2005, 121, 281–293. [CrossRef] [PubMed]
25. Foley, T.D., Petro, L.A., Stredny, C.M., Coppa, T.M. Oxidative Inhibition of Protein Phosphatase 2A Activity: Role of Catalytic Subunit Disulfides. Neurochem. Res. 2007, 32, 1957–1964. [CrossRef] [PubMed]
26. Truong, T.H., Carroll, K.S. Redox Regulation of Protein Kinases. Crit. Rev. Biochem. Mol. Biol. 2013, 48, 332–356. [CrossRef] [PubMed]
27. Corcoran, A., Cotter, T.G. Redox Regulation of Protein Kinases. FEBS J. 2013, 280, 1944–1965. [CrossRef] [PubMed]
28. Hempel, N., Trebak, M. Crosstalk between Calcium and Reactive Oxygen Species Signaling in Cancer. Cell Calcium 2017. [CrossRef] [PubMed]
29. Adachi, T., Weisbrod, R.M., Pimentel, D.R., Ying, J., Sharov, V.S., Schoneich, C., Cohen, R.A. S-Glutathiolation by Peroxynitrite Activates SERCA During Arterial Relaxation by Nitric Oxide. Nat. Med. 2004, 10, 1200–1207. [CrossRef] [PubMed]
30. Evangelista, A.M., Thompson, M.D., Bolotina, V.M., Tong, X., Cohen, R.A. Nox4- and Nox2-Dependent Oxidant Production Is Required for VEGF-Induced SERCA Cysteine-674 S-Glutathiolation and Endothelial Cell Migration. Free Radic. Biol. Med. 2012, 53, 2327–2334. [CrossRef] [PubMed]
31. Brandes, R.P., Weissmann, N., Schroder, K. Nox Family NADPH Oxidases: Molecular Mechanisms of Activation. Free Radic. Biol. Med. 2014, 76, 208–226. [CrossRef] [PubMed]
32. Maher, J., Yamamoto, M. The Rise of Antioxidant Signaling—The Evolution and Hormetic Actions of Nrf 2. Toxicol. Appl. Pharmacol. 2010, 244, 4–15. [CrossRef] [PubMed]
33. Hainaut, P., Milner, J. Redox Modulation of P53 Conformation and Sequence-Specific DNA Binding in Vitro. Cancer Res. 1993, 53, 4469–4473. [PubMed]
34. Lando, D., Pongratz, I., Poellinger, L., Whitelaw, M.L.: A Redox Mechanism Controls Differential DNA Binding Activities of Hypoxia-Inducible Factor (HIF) 1alpha and the HIF-Like Factor. J. Biol. Chem. 2000, 275, 4618–4627. [CrossRef] [PubMed]
35. Glineur, C., Davioud-Charvet, E., Vandenbunder, B. The Conserved Redox-Sensitive Cysteine Residue of the DNA-Binding Region in the C-Rel Protein Is Involved in the Regulation of the Phosphorylation of the Protein. Biochem. J. 2000, 352 Pt 2, 583–591. [CrossRef] [PubMed]
36. Janssen-Heininger, Y.M., Poynter, M.E., Baeuerle, P.A. Recent Advances Towards Understanding Redox Mechanisms in the Activation of Nuclear Factor KappaB. Free Radic. Biol. Med. 2000, 28, 1317–1327. [CrossRef]
37. Tell, G., Zecca, A., Pellizzari, L., Spessotto, P., Colombatti, A., Kelley, M.R., Damante, G., Pucillo, C. An ‘Environment to Nucleus’ Signaling System Operates in B Lymphocytes: Redox Status Modulates BSAP/Pax-5 Activation through Ref-1 Nuclear Translocation. Nucleic Acids Res. 2000, 28, 1099–1105. [CrossRef] [PubMed]
38. Cao, X., Kambe, F., Ohmori, S., Seo, H. Oxidoreductive Modification of Two Cysteine Residues in Paired Domain by Ref-1 Regulates DNA-Binding Activity of Pax-8. Biochem. Biophys. Res. Commun. 2002, 297, 288–293. [CrossRef]
39. Huang, R.P., Adamson, E.D. Characterization of the DNA-Binding Properties of the Early Growth Response-1 (Egr-1) Transcription Factor: Evidence for Modulation by a Redox Mechanism. DNA Cell Biol. 1993, 12, 265–273. [CrossRef] [PubMed]
40. Xanthoudakis, S., Miao, G., Wang, F., Pan, Y.C., Curran, T. Redox Activation of Fos-Jun DNA Binding Activity Is Mediated by a DNA Repair Enzyme. EMBO J. 1992, 11, 3323–3335. [PubMed]
41. Tell, G., Quadrifoglio, F., Tiribelli, C., Kelley, M.R. The Many Functions of APE1/Ref-1: Not Only a DNA Repair Enzyme. Antioxid. Redox Signal. 2009, 11, 601–620. [CrossRef] [PubMed]
42. Doyle, K., Fitzpatrick, F.A. Redox Signaling, Alkylation (Carbonylation) of Conserved Cysteines Inactivates Class I Histone Deacetylases 1, 2, and 3 and Antagonizes Their Transcriptional Repressor Function. J. Biol. Chem. 2010, 285, 17417–17424. [CrossRef] [PubMed]
43. Weitzman, S.A., Turk, P.W., Milkowski, D.H., Kozlowski, K. Free Radical Adducts Induce Alterations in DNA Cytosine Methylation. Proc. Natl. Acad. Sci. USA 1994, 91, 1261–1264. [CrossRef] [PubMed]
44. Turk, P.W., Laayoun, A., Smith, S.S., Weitzman, S.A. DNA Adduct 8-Hydroxyl-2’-Deoxyguanosine (8-Hydroxyguanine) Affects Function of Human DNA Methyltransferase. Carcinogenesis 1995, 16, 1253–1255. [CrossRef] [PubMed]
45. Parker, M.D., Chambers, P.A., Lodge, J.P., Pratt, J.R. Ischemia- Reperfusion Injury and Its Influence on the Epigenetic Modification of the Donor Kidney Genome. Transplantation 2008, 86, 1818–1823. [CrossRef] [PubMed]
46. Valinluck, V., Tsai, H.H., Rogstad, D.K., Burdzy, A., Bird, A., Sowers, L.C. Oxidative Damage to Methyl-CpG Sequences Inhibits the Binding of the Methyl-CpG Binding Domain (MBD) of Methyl-CpG Binding Protein 2 (MeCP2). Nucleic Acids Res. 2004, 32, 4100–4108. [CrossRef] [PubMed]
47. Poyton, R.O., Ball, K.A., Castello, P.R. Mitochondrial Generation of Free Radicals and Hypoxic Signaling. Trends Endocrinol. Metab. 2009, 20, 332–340. [CrossRef] [PubMed]
48. Nauseef, W.M.: Biological Roles for the NOX Family NADPH Oxidases. J. Biol. Chem. 2008, 283, 16961–16965. [CrossRef] [PubMed]
49. Bedard, K., Krause, K.H. The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology. Physiol. Rev. 2007, 87, 245–313. [CrossRef] [PubMed]
50. Rada, B., Hably, C., Meczner, A., Timar, C., Lakatos, G., Enyedi, P., Ligeti, E. Role of Nox2 in Elimination of Microorganisms. Semin. Immunopathol. 2008, 30, 237–253. [CrossRef] [PubMed]
51. Beaumel, S., Grunwald, D., Fieschi, F., Stasia, M.J. Identification of NOX2 Regions for Normal Biosynthesis of Cytochrome B558 in Phagocytes Highlighting Essential Residues for P22phox Binding. Biochem. J. 2014, 464, 425–437. [CrossRef] [PubMed]
52. Borregaard, N., Heiple, J.M., Simons, E.R., Clark, R.A. Subcellular Localization of the B-Cytochrome Component of the Human Neutrophil Microbicidal Oxidase: Translocation during Activation. J. Cell. Biol. 1983, 97, 52–61. [CrossRef] [PubMed]
53. Lundqvist, H., Follin, P., Khalfan, L., Dahlgren, C. Phorbol Myristate Acetate-Induced NADPH Oxidase Activity in Human Neutrophils: Only Half the Story Has Been Told. J. Leukoc. Biol. 1996, 59, 270–279. [PubMed]
54. Jones, S.A., O’Donnell, V.B., Wood, J.D., Broughton, J.P., Hughes, E.J., Jones, O.T. Expression of Phagocyte NADPH Oxidase Components in Human Endothelial Cells. Am. J. Physiol. 1996, 271, H1626–H1634. [PubMed]
55. Banfi, B., Clark, R.A., Steger, K., Krause, K.H. Two Novel Proteins Activate Superoxide Generation by the NADPH Oxidase NOX 1. J. Biol. Chem. 2003, 278, 3510–3513. [CrossRef] [PubMed]
56. Suh, Y.A., Arnold, R.S., Lassegue, B., Shi, J., Xu, X., Sorescu, D., Chung, A.B., Griendling, K.K., Lambeth, J.D. Cell Transformation by the Superoxide-Generating Oxidase Mox 1. Nature 1999, 401, 79–82. [PubMed]
57. Kobayashi, S., Nojima, Y., Shibuya, M., Maru, Y.: Nox1 Regulates Apoptosis and Potentially Stimulates Branching Morphogenesis in Sinusoidal Endothelial Cells. Exp. Cell Res. 2004, 300, 455–462. [CrossRef] [PubMed]
58. Lassegue, B., Sorescu, D., Szocs, K., Yin, Q., Akers, M., Zhang, Y., Grant, S.L., Lambeth, J.D., Griendling, K.K. Novel Gp91(Phox) Homologues in Vascular Smooth Muscle Cells: Nox1 Mediates Angiotensin II-Induced Superoxide Formation and Redox-Sensitive Signaling Pathways. Circ. Res. 2001, 88, 888–894. [CrossRef] [PubMed]
59. Katsuyama, M., Fan, C., Yabe-Nishimura, C. NADPH Oxidase Is Involved in Prostaglandin F2alpha-Induced Hypertrophy of Vascular Smooth Muscle Cells: Induction of NOX1 by PGF2alpha. J. Biol. Chem. 2002, 277, 13438–13442. [CrossRef] [PubMed]
60. Cheng, G., Diebold, B.A., Hughes, Y., Lambeth, J.D. Nox1-Dependent Reactive Oxygen Generation Is Regulated by Rac 1. J. Biol. Chem. 2006, 281, 17718–17726. [CrossRef] [PubMed]
61. Banfi, B., Malgrange, B., Knisz, J., Steger, K., Dubois-Dauphin, M., Krause, K.H. NOX3, a Superoxide- Generating NADPH Oxidase of the Inner Ear. J. Biol. Chem. 2004, 279, 46065–46072. [CrossRef] [PubMed]
62. Paffenholz, R., Bergstrom, R.A., Pasutto, F., Wabnitz, P., Munroe, R.J., Jagla, W., Heinzmann, U., Marquardt, A., Bareiss, A., Laufs, J., et al. Vestibular Defects in Head-Tilt Mice Result From Mutations in Nox3, Encoding an NADPH Oxidase. Genes Dev. 2004, 18, 486–491. [CrossRef] [PubMed]
63. Ueno, N., Takeya, R., Miyano, K., Kikuchi, H., Sumimoto, H. The NADPH Oxidase Nox3 Constitutively Produces Superoxide in a P22phox-Dependent Manner: Its Regulation by Oxidase Organizers and Activators. J. Biol. Chem. 2005, 280, 23328–23339. [CrossRef] [PubMed]
64. Nakano, Y., Longo-Guess, C.M., Bergstrom, D.E., Nauseef, W.M., Jones, S.M., Banfi, B.: Mutation of the Cyba Gene Encoding P22phox Causes Vestibular and Immune Defects in Mice. J. Clin. Investig. 2008, 118, 1176–1185. [CrossRef] [PubMed]
65. Kiss, P.J., Knisz, J., Zhang, Y., Baltrusaitis, J., Sigmund, C.D., Thalmann, R., Smith, R.J., Verpy, E., Banfi, B. Inactivation of NADPH Oxidase Organizer 1 Results in Severe Imbalance. Curr. Biol. 2006, 16, 208–213. [CrossRef] [PubMed]
66. Flaherty, J.P., Spruce, C.A., Fairfield, H.E., Bergstrom, D.E. Generation of a Conditional Null Allele of NADPH Oxidase Activator 1 (NOXA1). Genesis 2010, 48, 568–575. [CrossRef] [PubMed]
67. Ago, T., Kitazono, T., Ooboshi, H., Iyama, T., Han, Y.H., Takada, J., Wakisaka, M., Ibayashi, S., Utsumi, H., Iida, M. Nox4 As the Major Catalytic Component of an Endothelial NAD(P)H Oxidase. Circulation 2004, 109, 227–233. [CrossRef] [PubMed]
68. Geiszt, M., Kopp, J.B., Varnai, P., Leto, T.L. Identification of Renox, an NAD(P)H Oxidase in Kidney. Proc. Natl. Acad. Sci. USA 2000, 97, 8010–8014. [CrossRef] [PubMed]
69. Ambasta, R.K., Kumar, P., Griendling, K.K., Schmidt, H.H., Busse, R., Brandes, R.P. Direct Interaction of the Novel Nox Proteins With P22phox Is Required for the Formation of a Functionally Active NADPH Oxidase. J. Biol. Chem. 2004, 279, 45935–45941. [CrossRef] [PubMed]
70. Martyn, K.D., Frederick, L.M., von Loehneysen, K., Dinauer, M.C., Knaus, U.G. Functional Analysis of Nox4 Reveals Unique Characteristics Compared to Other NADPH Oxidases. Cell Signal. 2006, 18, 69–82. [CrossRef] [PubMed]
71. Kuroda, J., Nakagawa, K., Yamasaki, T., Nakamura, K., Takeya, R., Kuribayashi, F., Imajoh-Ohmi, S., Igarashi, K., Shibata, Y., Sueishi, K., et al. The Superoxide-Producing NAD(P)H Oxidase Nox4 in the Nucleus of Human Vascular Endothelial Cells. Genes Cells 2005, 10, 1139–1151. [CrossRef] [PubMed]
72. Mandal, C.C., Ganapathy, S., Gorin, Y., Mahadev, K., Block, K., Abboud, H.E., Harris, S.E., Ghosh-Choudhury, G., Ghosh-Choudhury, N.: Reactive Oxygen Species Derived From Nox4 Mediate BMP2 Gene Transcription and Osteoblast Differentiation. Biochem. J. 2011, 433, 393–402. [CrossRef] [PubMed]
73. Gorin, Y., Ricono, J.M., Kim, N.H., Bhandari, B., Choudhury, G.G., Abboud, H.E. Nox4 Mediates Angiotensin II-Induced Activation of Akt/Protein Kinase B in Mesangial Cells. Am. J. Physiol. Renal Physiol. 2003, 285, F219–F229. [CrossRef] [PubMed]
74. Serrander, L., Jaquet, V., Bedard, K., Plastre, O., Hartley, O., Arnaudeau, S., Demaurex, N., Schlegel, W., Krause, K.H. NOX5 Is Expressed at the Plasma Membrane and Generates Superoxide in Response to Protein Kinase C Activation. Biochimie 2007, 89, 1159–1167. [CrossRef] [PubMed]
75. Brar, S.S., Corbin, Z., Kennedy, T.P., Hemendinger, R., Thornton, L., Bommarius, B., Arnold, R.S., Whorton, A.R., Sturrock, A.B., Huecksteadt, T.P., et al. NOX5 NAD(P)H Oxidase Regulates Growth and Apoptosis in DU 145 Prostate Cancer Cells. Am. J. Physiol. Cell Physiol. 2003, 285, C353–C369. [CrossRef] [PubMed]
76. Kamiguti, A.S., Serrander, L., Lin, K., Harris, R.J., Cawley, J.C., Allsup, D.J., Slupsky, J.R., Krause, K.H., Zuzel, M.: Expression and Activity of NOX5 in the Circulating Malignant B Cells of Hairy Cell Leukemia. J. Immunol. 2005, 175, 8424–8430. [CrossRef] [PubMed]
77. Si, J., Fu, X., Behar, J., Wands, J., Beer, D.G., Souza, R.F., Spechler, S.J., Lambeth, D., Cao, W. NADPH Oxidase NOX5-S Mediates Acid-Induced Cyclooxygenase-2 Expression Via Activation of NF-KappaB in Barrett’s Esophageal Adenocarcinoma Cells. J. Biol. Chem. 2007, 282, 16244–16255. [CrossRef] [PubMed]
78. Banfi, B., Molnar, G., Maturana, A., Steger, K., Hegedus, B., Demaurex, N., Krause, K.H. A Ca2+-Activated NADPH Oxidase in Testis, Spleen, and Lymph Nodes. J. Biol. Chem. 2001, 276, 37594–37601. [CrossRef] [PubMed]
79. Cheng, G., Cao, Z., Xu, X., van Meir, E.G., Lambeth, J.D. Homologs of Gp91phox: Cloning and Tissue Expression of Nox3, Nox4, and Nox 5. Gene 2001, 269, 131–140. [CrossRef]
80. De, D.X., Wang, D., Many, M.C., Costagliola, S., Libert, F., Vassart, G., Dumont, J.E., Miot, F. Cloning of Two Human Thyroid CDNAs Encoding New Members of the NADPH Oxidase Family. J. Biol. Chem. 2000, 275, 23227–23233.
81. Dupuy, C., Ohayon, R., Valent, A., Noel-Hudson, M.S., Deme, D., Virion, A.: Purification of a Novel Flavoprotein Involved in the Thyroid NADPH Oxidase. Cloning of the Porcine and Human Cdnas. J. Biol. Chem. 1999, 274, 37265–37269. [CrossRef] [PubMed]
82. Morand, S., Dos Santos, O.F., Ohayon, R., Kaniewski, J., Noel-Hudson, M.S., Virion, A., Dupuy, C. Identification of a Truncated Dual Oxidase 2 (DUOX2) Messenger Ribonucleic Acid (MRNA) in Two Rat Thyroid Cell Lines. Insulin and Forskolin Regulation of DUOX2 MRNA Levels in FRTL-5 Cells and Porcine Thyrocytes. Endocrinology 2003, 144, 567–574. [CrossRef] [PubMed]
83. Grasberger, H., Refetoff, S. Identification of the Maturation Factor for Dual Oxidase. Evolution of an Eukaryotic Operon Equivalent. J. Biol. Chem. 2006, 281, 18269–18272. [CrossRef] [PubMed]
84. Hilenski, L.L., Clempus, R.E., Quinn, M.T., Lambeth, J.D., Griendling, K.K.: Distinct Subcellular Localizations of Nox1 and Nox4 in Vascular Smooth Muscle Cells. Arterioscler. Thromb. Vasc. Biol. 2004, 24, 677–683. [CrossRef] [PubMed]
85. Miller, F.J., Jr., Filali, M., Huss, G.J., Stanic, B., Chamseddine, A., Barna, T.J., Lamb, F.S. Cytokine Activation of Nuclear Factor Kappa B in Vascular Smooth Muscle Cells Requires Signaling Endosomes Containing Nox1 and ClC-3. Circ. Res. 2007, 101, 663–671. [CrossRef] [PubMed]
86. Petry, A., Djordjevic, T., Weitnauer, M., Kietzmann, T., Hess, J., Gorlach, A. NOX2 and NOX4 Mediate Proliferative Response in Endothelial Cells. Antioxid. Redox Signal. 2006, 8, 1473–1484. [CrossRef] [PubMed]
87. Hahn, N.E., Meischl, C., Wijnker, P.J., Musters, R.J., Fornerod, M., Janssen, H.W., Paulus, W.J., van Rossum, A.C., Niessen, H.W., Krijnen, P.A. NOX2, P22phox and P47phox Are Targeted to the Nuclear Pore Complex in Ischemic Cardiomyocytes Colocalizing With Local Reactive Oxygen Species. Cell. Physiol. Biochem. 2011, 27, 471–478. [CrossRef] [PubMed]
88. Laurindo, F.R., Araujo, T.L., Abrahao, T.B.: Nox NADPH Oxidases and the Endoplasmic Reticulum. Antioxid. Redox Signal. 2014, 20, 2755–2775. [CrossRef] [PubMed]
89. Das, R., Xu, S., Quan, X., Nguyen, T.T., Kong, I.D., Chung, C.H., Lee, E.Y., Cha, S.K., Park, K.S. Upregulation of Mitochondrial Nox4 Mediates TGF-Beta-Induced Apoptosis in Cultured Mouse Podocytes. Am. J. Physiol. Renal Physiol. 2014, 306, F155–F167. [CrossRef] [PubMed]
90. Roumenina, L.T., Rayes, J., Frimat, M., Fremeaux-Bacchi, V. Endothelial Cells: Source, Barrier, and Target of Defensive Mediators. Immunol. Rev. 2016, 274, 307–329. [CrossRef] [PubMed]
91. Ando, J., Yamamoto, K.: Flow Detection and Calcium Signalling in Vascular Endothelial Cells. Cardiovasc. Res. 2013, 99, 260–268. [CrossRef] [PubMed]
92. Van Hinsbergh, V.W.: Endothelium—Role in Regulation of Coagulation and Inflammation. Semin. Immunopathol. 2012, 34, 93–106. [CrossRef] [PubMed]
93. Lenting, P.J., Christophe, O.D., Denis, C.V. Von Willebr and Factor Biosynthesis, Secretion, and Clearance: Connecting the Far Ends. Blood 2015, 125, 2019–2028. [CrossRef] [PubMed]
94. Osborn, L., Hession, C., Tizard, R., Vassallo, C., Luhowskyj, S., Chi-Rosso, G., Lobb, R. Direct Expression Cloning of Vascular Cell Adhesion Molecule 1, a Cytokine-Induced Endothelial Protein That Binds to Lymphocytes. Cell 1989, 59, 1203–1211. [CrossRef]
95. Renkonen, R. Regulation of Intercellular Adhesion Molecule-1 Expression on Endothelial Cells with Correlation to Lymphocyte-Endothelial Binding. Scand. J. Immunol. 1989, 29, 717–721. [CrossRef] [PubMed]
96. Golebiewska, E.M., Poole, A.W. Platelet Secretion: From Haemostasis to Wound Healing and Beyond. Blood Rev. 2015, 29, 153–162. [CrossRef] [PubMed]
97. Bir, S.C., Kolluru, G.K., Fang, K., Kevil, C.G.: Redox Balance Dynamically Regulates Vascular Growth and Remodeling. Semin. Cell Dev. Biol. 2012, 23, 745–757. [CrossRef] [PubMed]
98. Panieri, E., Santoro, M.M.: ROS Signaling and Redox Biology in Endothelial Cells. Cell. Mol. Life Sci. 2015, 72, 3281–3303. [CrossRef] [PubMed]
99. Takac, I., Schroder, K., Brandes, R.P. The Nox Family of NADPH Oxidases: Friend or Foe of the Vascular System? Curr. Hypertens. Rep. 2012, 14, 70–78. [CrossRef] [PubMed]
100. Ushio-Fukai, M., Nakamura, Y. Reactive Oxygen Species and Angiogenesis: NADPH Oxidase as Target for Cancer Therapy. Cancer Lett. 2008, 266, 37–52. [CrossRef] [PubMed]
101. Monte, M., Davel, L.E., Sacerdote, D.L. Hydrogen Peroxide Is Involved in Lymphocyte Activation Mechanisms to Induce Angiogenesis. Eur. J. Cancer 1997, 33, 676–682. [CrossRef]
102. Yasuda, M., Ohzeki, Y., Shimizu, S., Naito, S., Ohtsuru, A., Yamamoto, T., Kuroiwa, Y. Stimulation of in Vitro Angiogenesis by Hydrogen Peroxide and the Relation With ETS-1 in Endothelial Cells. Life Sci. 1999, 64, 249–258. [CrossRef]
103. Chen, W., Gabel, S., Steenbergen, C., Murphy, E. A Redox-Based Mechanism for Cardioprotection Induced by Ischemic Preconditioning in Perfused Rat Heart. Circ. Res. 1995, 77, 424–429. [CrossRef] [PubMed]
104. Skyschally, A., Schulz, R., Gres, P., Korth, H.G., Heusch, G. Attenuation of Ischemic Preconditioning in Pigs by Scavenging of Free Oxyradicals With Ascorbic Acid. Am. J. Physiol. Heart Circ. Physiol. 2003, 284, H698–H703. [CrossRef] [PubMed]
105. Tanaka, K., Weihrauch, D., Kehl, F., Ludwig, L.M., LaDisa, J.F., Jr., Kersten, J.R., Pagel, P.S., Warltier, D.C. Mechanism of Preconditioning by Isoflurane in Rabbits: A Direct Role for Reactive Oxygen Species. Anesthesiology 2002, 97, 1485–1490. [CrossRef] [PubMed]
106. Brakenhielm, E., Cao, R., Cao, Y. Suppression of Angiogenesis, Tumor Growth, and Wound Healing by Resveratrol, a Natural Compound in Red Wine and Grapes. FASEB J. 2001, 15, 1798–1800. [CrossRef] [PubMed]
107. Oak, M.H., El Bedoui, J., Schini-Kerth, V.B.: Antiangiogenic Properties of Natural Polyphenols from Red Wine and Green Tea. J. Nutr. Biochem. 2005, 16, 1–8. [CrossRef] [PubMed]
108. Yamaoka-Tojo, M., Ushio-Fukai, M., Hilenski, L., Dikalov, S.I., Chen, Y.E., Tojo, T., Fukai, T., Fujimoto, M., Patrushev, N.A., Wang, N., et al. IQGAP1, a Novel Vascular Endothelial Growth Factor Receptor Binding Protein, Is Involved in Reactive Oxygen Species—Dependent Endothelial Migration and Proliferation. Circ. Res. 2004, 95, 276–283. [CrossRef] [PubMed]
109. Harfouche, R., Malak, N.A., Brandes, R.P., Karsan, A., Irani, K., Hussain, S.N. Roles of Reactive Oxygen Species in Angiopoietin-1/Tie-2 Receptor Signaling. FASEB J. 2005, 19, 1728–1730. [CrossRef] [PubMed]
110. Kim, Y.M., Kim, K.E., Koh, G.Y., Ho, Y.S., Lee, K.J. Hydrogen Peroxide Produced by Angiopoietin-1 Mediates Angiogenesis. Cancer Res. 2006, 66, 6167–6174. [CrossRef] [PubMed]
111. Craige, S.M., Kant, S., Keaney, J.F., Jr. Reactive Oxygen Species in Endothelial Function—From Disease to Adaptation. Circ. J. 2015, 79, 1145–1155. [CrossRef] [PubMed]
112. Gavard, J., Gutkind, J.S. VEGF Controls Endothelial-Cell Permeability by Promoting the Beta-Arrestin- Dependent Endocytosis of VE-Cadherin. Nat. Cell Biol. 2006, 8, 1223–1234. [CrossRef] [PubMed]
113. Moldovan, L., Moldovan, N.I., Sohn, R.H., Parikh, S.A., Goldschmidt-Clermont, P.J. Redox Changes of Cultured Endothelial Cells and Actin Dynamics. Circ. Res. 2000, 86, 549–557. [CrossRef] [PubMed]
114. Ikeda, S., Yamaoka-Tojo, M., Hilenski, L., Patrushev, N.A., Anwar, G.M., Quinn, M.T., Ushio-Fukai, M. IQGAP1 Regulates Reactive Oxygen Species-Dependent Endothelial Cell Migration Through Interacting With Nox 2. Arterioscler. Thromb. Vasc. Biol. 2005, 25, 2295–2300. [CrossRef] [PubMed]
115. Wu, R.F., Gu, Y., Xu, Y.C., Nwariaku, F.E., Terada, L.S. Vascular Endothelial Growth Factor Causes Translocation of P47phox to Membrane Ruffles Through WAVE 1. J. Biol. Chem. 2003, 278, 36830–36840. [CrossRef] [PubMed]
116. Chen, K., Kirber, M.T., Xiao, H., Yang, Y., Keaney, J.F., Jr. Regulation of ROS Signal Transduction by NADPH Oxidase 4 Localization. J. Cell. Biol. 2008, 181, 1129–1139. [CrossRef] [PubMed]
117. Craige, S.M., Chen, K., Pei, Y., Li, C., Huang, X., Chen, C., Shibata, R., Sato, K., Walsh, K., Keaney, J.F., Jr.. NADPH Oxidase 4 Promotes Endothelial Angiogenesis Through Endothelial Nitric Oxide Synthase Activation. Circulation 2011, 124, 731–740. [CrossRef] [PubMed]
118. Schroder, K., Zhang, M., Benkhoff, S., Mieth, A., Pliquett, R., Kosowski, J., Kruse, C., Luedike, P., Michaelis, U.R., Weissmann, N., et al. Nox4 Is a Protective Reactive Oxygen Species Generating Vascular NADPH Oxidase. Circ. Res. 2012, 110, 1217–1225. [CrossRef] [PubMed]
119. Ushio-Fukai, M., Alexander, R.W. Reactive Oxygen Species As Mediators of Angiogenesis Signaling: Role of NAD(P)H Oxidase. Mol. Cell. Biochem. 2004, 264, 85–97. [CrossRef] [PubMed]
120. Griendling, K.K. Novel NAD(P)H Oxidases in the Cardiovascular System. Heart 2004, 90, 491–493. [CrossRef] [PubMed]
121. Ushio-Fukai, M., Urao, N.: Novel Role of NADPH Oxidase in Angiogenesis and Stem/Progenitor Cell Function. Antioxid. Redox Signal. 2009, 11, 2517–2533. [CrossRef] [PubMed]
122. Guzik, T.J., Sadowski, J., Kapelak, B., Jopek, A., Rudzinski, P., Pillai, R., Korbut, R., Channon, K.M. Systemic Regulation of Vascular NAD(P)H Oxidase Activity and Nox Isoform Expression in Human Arteries and Veins. Arterioscler. Thromb. Vasc. Biol. 2004, 24, 1614–1620. [CrossRef] [PubMed]
123. Van Buul, J.D., Fernandez-Borja, M., Anthony, E.C., Hordijk, P.L. Expression and Localization of NOX2 and NOX4 in Primary Human Endothelial Cells. Antioxid. Redox Signal. 2005, 7, 308–317. [CrossRef] [PubMed]
124. Ushio-Fukai, M.: Compartmentalization of Redox Signaling Through NADPH Oxidase-Derived ROS. Antioxid. Redox Signal. 2009, 11, 1289–1299. [CrossRef] [PubMed]
125. Gavazzi, G., Banfi, B., Deffert, C., Fiette, L., Schappi, M., Herrmann, F., Krause, K.H. Decreased Blood Pressure in NOX1-Deficient Mice. FEBS Lett. 2006, 580, 497–504. [CrossRef] [PubMed]
126. Matsuno, K., Yamada, H., Iwata, K., Jin, D., Katsuyama, M., Matsuki, M., Takai, S., Yamanishi, K., Miyazaki, M., Matsubara, H., et al. Nox1 Is Involved in Angiotensin II-Mediated Hypertension: A Study in Nox1-Deficient Mice. Circulation 2005, 112, 2677–2685. [CrossRef] [PubMed]
127. Murdoch, C.E., Chaubey, S., Zeng, L., Yu, B., Ivetic, A., Walker, S.J., Vanhoutte, D., Heymans, S., Grieve, D.J., Cave, A.C., et al. Endothelial NADPH Oxidase-2 Promotes Interstitial Cardiac Fibrosis and Diastolic Dysfunction Through Proinflammatory Effects and Endothelial-Mesenchymal Transition. J. Am. Coll. Cardiol. 2014, 63, 2734–2741. [CrossRef] [PubMed]
128. Sag, C.M., Schnelle, M., Zhang, J., Murdoch, C.E., Kossmann, S., Protti, A., Santos, C.X., Sawyer, G.J., Zhang, X., Mongue-Din, H., et al. Distinct Regulatory Effects of Myeloid Cell and Endothelial Cell Nox2 on Blood Pressure. Circulation 2017. [CrossRef]
129. Montezano, A.C., Tsiropoulou, S., Dulak-Lis, M., Harvey, A., Camargo, L.L., Touyz, R.M. Redox Signaling, Nox5 and Vascular Remodeling in Hypertension. Curr. Opin. Nephrol. Hypertens. 2015, 24, 425–433. [CrossRef] [PubMed]
130. Wilkinson-Berka, J.L., Rana, I., Armani, R., Agrotis, A. Reactive Oxygen Species, Nox and Angiotensin II in Angiogenesis: Implications for Retinopathy. Clin. Sci. (Lond.) 2013, 124, 597–615. [CrossRef] [PubMed]
131. Guzik, T.J., Chen, W., Gongora, M.C., Guzik, B., Lob, H.E., Mangalat, D., Hoch, N., Dikalov, S., Rudzinski, P., Kapelak, B., et al. Calcium-Dependent NOX5 Nicotinamide Adenine Dinucleotide Phosphate Oxidase Contributes to Vascular Oxidative Stress in Human Coronary Artery Disease. J. Am. Coll. Cardiol. 2008, 52, 1803–1809. [CrossRef] [PubMed]
132. Manea, A., Manea, S.A., Gan, A.M., Constantin, A., Fenyo, I.M., Raicu, M., Muresian, H., Simionescu, M.: Human Monocytes and Macrophages Express NADPH Oxidase 5, a Potential Source of Reactive Oxygen Species in Atherosclerosis. Biochem. Biophys. Res. Commun. 2015, 461, 172–179. [CrossRef] [PubMed]
133. Schroder, K., Helmcke, I., Palfi, K., Krause, K.H., Busse, R., Brandes, R.P. Nox1 Mediates Basic Fibroblast Growth Factor-Induced Migration of Vascular Smooth Muscle Cells. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 1736–1743. [CrossRef] [PubMed]
134. Komatsu, D., Kato, M., Nakayama, J., Miyagawa, S., Kamata, T. NADPH Oxidase 1 Plays a Critical Mediating Role in Oncogenic Ras-Induced Vascular Endothelial Growth Factor Expression. Oncogene 2008, 27, 4724–4732. [CrossRef] [PubMed]
135. Garrido-Urbani, S., Jemelin, S., Deffert, C., Carnesecchi, S., Basset, O., Szyndralewiez, C., Heitz, F., Page, P., Montet, X., Michalik, L., et al. Targeting Vascular NADPH Oxidase 1 Blocks Tumor Angiogenesis Through a PPARalpha Mediated Mechanism. PLoS ONE 2011, 6, e14665. [CrossRef]
136. Peshavariya, H., Dusting, G.J., Jiang, F., Halmos, L.R., Sobey, C.G., Drummond, G.R., Selemidis, S. NADPH Oxidase Isoform Selective Regulation of Endothelial Cell Proliferation and Survival. Naunyn Schmiedebergs Arch. Pharmacol. 2009, 380, 193–204. [CrossRef] [PubMed]
137. Diebold, I., Djordjevic, T., Petry, A., Hatzelmann, A., Tenor, H., Hess, J., Gorlach, A. Phosphodiesterase 2 Mediates Redox-Sensitive Endothelial Cell Proliferation and Angiogenesis by Thrombin Via Rac1 and NADPH Oxidase 2. Circ. Res. 2009, 104, 1169–1177. [CrossRef] [PubMed]
138. Tojo, T., Ushio-Fukai, M., Yamaoka-Tojo, M., Ikeda, S., Patrushev, N., Alexander, R.W. Role of Gp91phox (Nox2)-Containing NAD(P)H Oxidase in Angiogenesis in Response to Hindlimb Ischemia. Circulation 2005, 111, 2347–2355. [CrossRef] [PubMed]
139. Urao, N., Inomata, H., Razvi, M., Kim, H.W., Wary, K., McKinney, R., Fukai, T., Ushio-Fukai, M. Role of Nox2-Based NADPH Oxidase in Bone Marrow and Progenitor Cell Function Involved in Neovascularization Induced by Hindlimb Ischemia. Circ. Res. 2008, 103, 212–220. [CrossRef] [PubMed]
140. Ushio-Fukai, M., Tang, Y., Fukai, T., Dikalov, S.I., Ma, Y., Fujimoto, M., Quinn, M.T., Pagano, P.J., Johnson, C., Alexander, R.W. Novel Role of Gp91(Phox)-Containing NAD(P)H Oxidase in Vascular Endothelial Growth Factor-Induced Signaling and Angiogenesis. Circ. Res. 2002, 91, 1160–1167. [CrossRef] [PubMed]
141. Diebold, I., Petry, A., Sabrane, K., Djordjevic, T., Hess, J., Gorlach, A. The HIF1 Target Gene NOX2 Promotes Angiogenesis Through Urotensin-II. J. Cell. Sci. 2012, 125, 956–964. [CrossRef] [PubMed]
142. Ebrahimian, T.G., Heymes, C., You, D., Blanc-Brude, O., Mees, B., Waeckel, L., Duriez, M., Vilar, J., Brandes, R.P., Levy, B.I., et al. NADPH Oxidase-Derived Overproduction of Reactive Oxygen Species Impairs Postischemic Neovascularization in MiceWith Type 1 Diabetes. Am. J. Pathol. 2006, 169, 719–728. [CrossRef] [PubMed]
143. Haddad, P., Dussault, S., Groleau, J., Turgeon, J., Maingrette, F., Rivard, A. Nox2-Derived Reactive Oxygen Species Contribute to Hypercholesterolemia-Induced Inhibition of Neovascularization: Effects on Endothelial Progenitor Cells and Mature Endothelial Cells. Atherosclerosis 2011, 217, 340–349. [CrossRef] [PubMed]
144. Ellmark, S.H., Dusting, G.J., Fui, M.N., Guzzo-Pernell, N., Drummond, G.R. The Contribution of Nox4 to NADPH Oxidase Activity in Mouse Vascular Smooth Muscle. Cardiovasc. Res. 2005, 65, 495–504. [CrossRef] [PubMed]
145. Datla, S.R., Peshavariya, H., Dusting, G.J., Mahadev, K., Goldstein, B.J., Jiang, F. Important Role of Nox4 Type NADPH Oxidase in Angiogenic Responses in Human Microvascular Endothelial Cells in Vitro. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 2319–2324. [CrossRef] [PubMed]
146. Hakami, N.Y., Ranjan, A.K., Hardikar, A.A., Dusting, G.J., Peshavariya, H.M. Role of NADPH Oxidase-4 in Human Endothelial Progenitor Cells. Front. Physiol. 2017, 8, 150. [CrossRef] [PubMed]
147. Chen, L., Xiao, J., Kuroda, J., Ago, T., Sadoshima, J., Cohen, R.A., Tong, X.: Both Hydrogen Peroxide and Transforming Growth Factor Beta 1 Contribute to Endothelial Nox4 Mediated Angiogenesis in Endothelial Nox4 Transgenic Mouse Lines. Biochim. Biophys. Acta 2014, 1842, 2489–2499. [CrossRef] [PubMed]
148. Byrne, J.A., Grieve, D.J., Bendall, J.K., Li, J.M., Gove, C., Lambeth, J.D., Cave, A.C., Shah, A.M. Contrasting Roles of NADPH Oxidase Isoforms in Pressure-Overload Versus Angiotensin II-Induced Cardiac Hypertrophy. Circ. Res. 2003, 93, 802–805. [CrossRef] [PubMed]
149. Zhang, M., Brewer, A.C., Schroder, K., Santos, C.X., Grieve, D.J., Wang, M., Anilkumar, N., Yu, B., Dong, X., Walker, S.J., et al. NADPH Oxidase-4 Mediates Protection Against Chronic Load-Induced Stress in Mouse Hearts by Enhancing Angiogenesis. Proc. Natl. Acad. Sci. USA 2010, 107, 18121–18126. [CrossRef] [PubMed]
150. Vogel, J., Kruse, C., Zhang, M., Schroder, K. Nox4 Supports Proper Capillary Growth in Exercise and Retina Neo-Vascularization. J. Physiol. 2015, 593, 2145–2154. [CrossRef] [PubMed]
151. Helfinger, V., Henke, N., Harenkamp, S., Walter, M., Epah, J., Penski, C., Mittelbronn, M., Schroder, K. The NADPH Oxidase Nox4 Mediates Tumour Angiogenesis. Acta Physiol. (Oxf.) 2016, 216, 435–446. [CrossRef] [PubMed]
152. Loboda, A., Jozkowicz, A., Dulak, J. HO-1/CO System in Tumor Growth, Angiogenesis and Metabolism—Targeting HO-1 As an Anti-Tumor Therapy. Vascul. Pharmacol. 2015, 74, 11–22. [CrossRef] [PubMed]
153. Chua, C.C., Hamdy, R.C., Chua, B.H. Upregulation of Vascular Endothelial Growth Factor by H2O2 in Rat Heart Endothelial Cells. Free Radic. Biol. Med. 1998, 25, 891–897. [CrossRef]
154. Iwakami, S., Misu, H., Takeda, T., Sugimori, M., Matsugo, S., Kaneko, S., Takamura, T. Concentration- Dependent Dual Effects of Hydrogen Peroxide on Insulin Signal Transduction in H4IIEC Hepatocytes. PLoS ONE 2011, 6, e27401. [CrossRef] [PubMed]
155. Zachary, I., Gliki, G. Signaling Transduction Mechanisms Mediating Biological Actions of the Vascular Endothelial Growth Factor Family. Cardiovasc. Res. 2001, 49, 568–581. [CrossRef]
156. Yuan, S., Kevil, C.G. Nitric Oxide and Hydrogen Sulfide Regulation of Ischemic Vascular Remodeling. Microcirculation 2016, 23, 134–145. [CrossRef] [PubMed]
157. Maraldi, T., Prata, C., Caliceti, C., Vieceli Dalla, S.F., Zambonin, L., Fiorentini, D., Hakim, G. VEGF-Induced ROS Generation From NAD(P)H Oxidases Protects Human Leukemic Cells From Apoptosis. Int. J. Oncol. 2010, 36, 1581–1589. [PubMed]
158. Soeda, S., Shimada, T., Koyanagi, S., Yokomatsu, T., Murano, T., Shibuya, S., Shimeno, H. An Attempt to Promote Neo-Vascularization by Employing a Newly Synthesized Inhibitor of Protein Tyrosine Phosphatase. FEBS Lett. 2002, 524, 54–58. [CrossRef]
159. Corti, F., Simons, M. Modulation of VEGF Receptor 2 Signaling by Protein Phosphatases. Pharmacol. Res. 2017, 115, 107–123. [CrossRef] [PubMed]
160. Cai, J., Jiang, W.G., Ahmed, A., Boulton, M.: Vascular Endothelial Growth Factor-Induced Endothelial Cell Proliferation Is Regulated by Interaction Between VEGFR-2, SH-PTP1 and ENOS. Microvasc. Res. 2006, 71, 20–31. [CrossRef] [PubMed]
161. Abdelsaid, M.A., El Remessy, A.B. S-Glutathionylation of LMW-PTP Regulates VEGF-Mediated FAK Activation and Endothelial Cell Migration. J. Cell Sci. 2012, 125, 4751–4760. [CrossRef] [PubMed]
162. Oshikawa, J., Urao, N., Kim, H.W., Kaplan, N., Razvi, M., McKinney, R., Poole, L.B., Fukai, T., Ushio-Fukai, M. Extracellular SOD-Derived H2O2 Promotes VEGF Signaling in Caveolae/Lipid Rafts and Post-Ischemic Angiogenesis in Mice. PLoS ONE 2010, 5, e10189. [CrossRef] [PubMed]
163. Wang, Z., Castresana, M.R., Newman, W.H.: Reactive Oxygen and NF-KappaB in VEGF-Induced Migration of Human Vascular Smooth Muscle Cells. Biochem. Biophys. Res. Commun. 2001, 285, 669–674. [CrossRef] [PubMed]
164. Wang, H., Yang, Z., Jiang, Y., Hartnett, M.E. Endothelial NADPH Oxidase 4 Mediates Vascular Endothelial Growth Factor Receptor 2-Induced Intravitreal Neovascularization in a Rat Model of Retinopathy of Prematurity. Mol. Vis. 2014, 20, 231–241. [PubMed]
165. Chen, X.L., Tummala, P.E., Olbrych, M.T., Alexander, R.W., Medford, R.M. Angiotensin II Induces Monocyte Chemoattractant Protein-1 Gene Expression in Rat Vascular Smooth Muscle Cells. Circ. Res. 1998, 83, 952–959. [CrossRef] [PubMed]
166. Tummala, P.E., Chen, X.L., Sundell, C.L., Laursen, J.B., Hammes, C.P., Alexander, R.W., Harrison, D.G., Medford, R.M. Angiotensin II Induces Vascular Cell Adhesion Molecule-1 Expression in Rat Vasculature: A Potential Link Between the Renin-Angiotensin System and Atherosclerosis. Circulation 1999, 100, 1223–1229. [CrossRef] [PubMed]
167. Galis, Z.S., Khatri, J.J.: Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: The Good, the Bad, and the Ugly. Circ. Res. 2002, 90, 251–262. [PubMed]
168. Alon, T., Hemo, I., Itin, A., Pe’er, J., Stone, J., Keshet, E.: Vascular Endothelial Growth Factor Acts As a Survival Factor for Newly Formed Retinal Vessels and Has Implications for Retinopathy of Prematurity. Nat. Med. 1995, 1, 1024–1028. [CrossRef] [PubMed]
169. Oliner, J.D., Bready, J., Nguyen, L., Estrada, J., Hurh, E., Ma, H., Pretorius, J., Fanslow, W., Nork, T.M., Leedle, R.A., et al. AMG 386, a Selective Angiopoietin 1/2-Neutralizing Peptibody, Inhibits Angiogenesis in Models of Ocular Neovascular Diseases. Investig. Ophthalmol. Vis. Sci. 2012, 53, 2170–2180. [CrossRef] [PubMed]
170. Chen, J., Connor, K.M., Aderman, C.M., Willett, K.L., Aspegren, O.P., Smith, L.E. Suppression of Retinal Neovascularization by Erythropoietin SiRNA in a Mouse Model of Proliferative Retinopathy. Investig. Ophthalmol. Vis. Sci. 2009, 50, 1329–1335. [CrossRef] [PubMed]
171. Xiong, S.Q., Xia, X.B., Xu, H.Z., Jiang, J. Suppression of Retinal Neovascularization by Small-Interference RNA Targeting Erythropoietin. Ophthalmologica 2009, 223, 306–312. [CrossRef] [PubMed]
172. Lima e Silva, R., Shen, J., Hackett, S.F., Kachi, S., Akiyama, H., Kiuchi, K., Yokoi, K., Hatara, M.C., Lauer, T., Aslam, S., et al. The SDF-1/CXCR4 Ligand/Receptor Pair Is an Important Contributor to Several Types of Ocular Neovascularization. FASEB J. 2007, 21, 3219–3230. [CrossRef] [PubMed]
173. Kietzmann, T., Gorlach, A. Reactive Oxygen Species in the Control of Hypoxia-Inducible Factor-Mediated Gene Expression. Semin. Cell Dev. Biol. 2005, 16, 474–486. [CrossRef] [PubMed]
174. Calvani, M., Comito, G., Giannoni, E., Chiarugi, P. Time-Dependent Stabilization of Hypoxia Inducible Factor-1alpha by Different Intracellular Sources of Reactive Oxygen Species. PLoS ONE 2012, 7, e38388. [CrossRef] [PubMed]
175. Goyal, P., Weissmann, N., Grimminger, F., Hegel, C., Bader, L., Rose, F., Fink, L., Ghofrani, H.A., Schermuly, R.T., Schmidt, H.H., et al. Upregulation of NAD(P)H Oxidase 1 in Hypoxia Activates Hypoxia-Inducible Factor 1 Via Increase in Reactive Oxygen Species. Free Radic. Biol. Med. 2004, 36, 1279–1288. [CrossRef] [PubMed]
176. Diebold, I., Petry, A., Hess, J., Gorlach, A. The NADPH Oxidase Subunit NOX4 Is a New Target Gene of the Hypoxia-Inducible Factor-1. Mol. Biol. Cell 2010, 21, 2087–2096. [CrossRef] [PubMed]
177. Dunn, L.L., Buckle, A.M., Cooke, J.P., Ng, M.K. The Emerging Role of the Thioredoxin System in Angiogenesis. Arterioscler. Thromb. Vasc. Biol. 2010, 30, 2089–2098. [CrossRef] [PubMed]
178. Kang, D.H., Lee, D.J., Lee, K.W., Park, Y.S., Lee, J.Y., Lee, S.H., Koh, Y.J., Koh, G.Y., Choi, C., Yu, D.Y., et al. Peroxiredoxin II Is an Essential Antioxidant Enzyme That Prevents the Oxidative Inactivation of VEGF Receptor-2 in Vascular Endothelial Cells. Mol. Cell 2011, 44, 545–558. [CrossRef] [PubMed]
179. Kim, Y.W., Byzova, T.V. Oxidative Stress in Angiogenesis and Vascular Disease. Blood 2014, 123, 625–631. [CrossRef] [PubMed]
180. Li, H., Horke, S., Forstermann, U. Vascular Oxidative Stress, Nitric Oxide and Atherosclerosis. Atherosclerosis 2014, 237, 208–219. [CrossRef] [PubMed]
181. Su, Q., Qin, D.N., Wang, F.X., Ren, J., Li, H.B., Zhang, M., Yang, Q., Miao, Y.W., Yu, X.J., Qi, J., et al. Inhibition of Reactive Oxygen Species in Hypothalamic Paraventricular Nucleus Attenuates the Renin-Angiotensin System and Proinflammatory Cytokines in Hypertension. Toxicol. Appl. Pharmacol. 2014, 276, 115–120. [CrossRef] [PubMed]
182. Zuo, L., Rose, B.A., Roberts, W.J., He, F., Banes-Berceli, A.K.: Molecular Characterization of Reactive Oxygen Species in Systemic and Pulmonary Hypertension. Am. J. Hypertens. 2014, 27, 643–650. [CrossRef] [PubMed]
183. Kaneto, H., Katakami, N., Matsuhisa, M., Matsuoka, T.A. Role of Reactive Oxygen Species in the Progression of Type 2 Diabetes and Atherosclerosis. Mediat. Inflamm. 2010, 2010, 453892. [CrossRef] [PubMed]
184. Konior, A., Schramm, A., Czesnikiewicz-Guzik, M., Guzik, T.J. NADPH Oxidases in Vascular Pathology. Antioxid. Redox Signal. 2014, 20, 2794–2814. [CrossRef] [PubMed]
185. Rajagopalan, S., Kurz, S., Munzel, T., Tarpey, M., Freeman, B.A., Griendling, K.K., Harrison, D.G. Angiotensin II-Mediated Hypertension in the Rat Increases Vascular Superoxide Production Via Membrane NADH/NADPH Oxidase Activation. Contribution to Alterations of Vasomotor Tone. J. Clin. Investig. 1996, 97, 1916–1923. [CrossRef] [PubMed]
186. Landmesser, U., Cai, H., Dikalov, S., McCann, L., Hwang, J., Jo, H., Holland, S.M., Harrison, D.G. Role of P47(Phox) in Vascular Oxidative Stress and Hypertension Caused by Angiotensin II. Hypertension 2002, 40, 511–515. [CrossRef] [PubMed]
187. Touyz, R.M.: Reactive Oxygen Species as Mediators of Calcium Signaling by Angiotensin II: Implications in Vascular Physiology and Pathophysiology. Antioxid. Redox Signal. 2005, 7, 1302–1314. [CrossRef] [PubMed]
188. Jung, O., Schreiber, J.G., Geiger, H., Pedrazzini, T., Busse, R., Brandes, R.P. Gp91phox-Containing NADPH Oxidase Mediates Endothelial Dysfunction in Renovascular Hypertension. Circulation 2004, 109, 1795–1801. [CrossRef] [PubMed]
189. Dikalova, A., Clempus, R., Lassegue, B., Cheng, G., McCoy, J., Dikalov, S., San Martin, A., Lyle, A., Weber, D.S., Weiss, D., et al. Nox1 Overexpression Potentiates Angiotensin II-Induced Hypertension and Vascular Smooth Muscle Hypertrophy in Transgenic Mice. Circulation 2005, 112, 2668–2676. [CrossRef] [PubMed]
190. Bendall, J.K., Rinze, R., Adlam, D., Tatham, A.L., de Bono, J., Wilson, N., Volpi, E., Channon, K.M. Endothelial Nox2 Overexpression Potentiates Vascular Oxidative Stress and Hemodynamic Response to Angiotensin II: Studies in Endothelial-Targeted Nox2 Transgenic Mice. Circ. Res. 2007, 100, 1016–1025. [CrossRef] [PubMed]
191. Ray, R., Murdoch, C.E., Wang, M., Santos, C.X., Zhang, M., Alom-Ruiz, S., Anilkumar, N., Ouattara, A., Cave, A.C., Walker, S.J., et al. Endothelial Nox4 NADPH Oxidase Enhances Vasodilatation and Reduces Blood Pressure in Vivo. Arterioscler. Thromb. Vasc. Biol. 2011, 31, 1368–1376. [CrossRef] [PubMed]
192. Lu, W., Kang, J., Hu, K., Tang, S., Zhou, X., Xu, L., Li, Y., Yu, S. The Role of the Nox4-Derived ROS-Mediated RhoA/Rho Kinase Pathway in Rat Hypertension Induced by Chronic Intermittent Hypoxia. Sleep Breath. 2017. [CrossRef] [PubMed]
193. Cowley, A.W., Jr., Yang, C., Zheleznova, N.N., Staruschenko, A., Kurth, T., Rein, L., Kumar, V., Sadovnikov, K., Dayton, A., Hoffman, M., et al. Evidence of the Importance of Nox4 in Production of Hypertension in Dahl Salt-Sensitive Rats. Hypertension 2016, 67, 440–450. [CrossRef] [PubMed]
194. Zhang, J., Chandrashekar, K., Lu, Y., Duan, Y., Qu, P., Wei, J., Juncos, L.A., Liu, R. Enhanced Expression and Activity of Nox2 and Nox4 in the Macula Densa in ANG II-Induced Hypertensive Mice. Am. J. Physiol. Renal Physiol. 2014, 306, F344–F350. [CrossRef] [PubMed]
195. Barman, S.A., Chen, F., Su, Y., Dimitropoulou, C., Wang, Y., Catravas, J.D., Han, W., Orfi, L., Szantai-Kis, C., Keri, G., et al. NADPH Oxidase 4 Is Expressed in Pulmonary Artery Adventitia and Contributes to Hypertensive Vascular Remodeling. Arterioscler. Thromb. Vasc. Biol. 2014, 34, 1704–1715. [CrossRef] [PubMed]
196. Violi, F., Pignatelli, P., Pignata, C., Plebani, A., Rossi, P., Sanguigni, V., Carnevale, R., Soresina, A., Finocchi, A., Cirillo, E., et al. Reduced Atherosclerotic Burden in Subjects With Genetically Determined Low Oxidative Stress. Arterioscler. Thromb. Vasc. Biol. 2013, 33, 406–412. [CrossRef] [PubMed]
197. Lee, M.Y., San Martin, A., Mehta, P.K., Dikalova, A.E., Garrido, A.M., Datla, S.R., Lyons, E., Krause, K.H., Banfi, B., Lambeth, J.D., et al. Mechanisms of Vascular Smooth Muscle NADPH Oxidase 1 (Nox1) Contribution to Injury-Induced Neointimal Formation. Arterioscler. Thromb. Vasc. Biol. 2009, 29, 480–487. [CrossRef] [PubMed]
198. Sorescu, D., Weiss, D., Lassegue, B., Clempus, R.E., Szocs, K., Sorescu, G.P., Valppu, L., Quinn, M.T., Lambeth, J.D., Vega, J.D., et al. Superoxide Production and Expression of Nox Family Proteins in Human Atherosclerosis. Circulation 2002, 105, 1429–1435. [CrossRef] [PubMed]
199. Guzik, T.J., Sadowski, J., Guzik, B., Jopek, A., Kapelak, B., Przybylowski, P., Wierzbicki, K., Korbut, R., Harrison, D.G., Channon, K.M.: Coronary Artery Superoxide Production and Nox Isoform Expression in Human Coronary Artery Disease. Arterioscler. Thromb. Vasc. Biol. 2006, 26, 333–339. [CrossRef] [PubMed]
200. Kirk, E.A., Dinauer, M.C., Rosen, H., Chait, A., Heinecke, J.W., LeBoeuf, R.C. Impaired Superoxide Production Due to a Deficiency in Phagocyte NADPH Oxidase Fails to Inhibit Atherosclerosis in Mice. Arterioscler. Thromb. Vasc. Biol. 2000, 20, 1529–1535. [CrossRef] [PubMed]
201. Hsich, E., Segal, B.H., Pagano, P.J., Rey, F.E., Paigen, B., Deleonardis, J., Hoyt, R.F., Holland, S.M., Finkel, T. Vascular Effects Following Homozygous Disruption of P47(Phox): An Essential Component of NADPH Oxidase. Circulation 2000, 101, 1234–1236. [CrossRef] [PubMed]
202. Barry-Lane, P.A., Patterson, C., van der, M.M., Hu, Z., Holland, S.M., Yeh, E.T., Runge, M.S. P47phox Is Required for Atherosclerotic Lesion Progression in ApoE(-/-) Mice. J. Clin. Investig. 2001, 108, 1513–1522. [CrossRef] [PubMed]
203. Liang, C.F., Liu, J.T., Wang, Y., Xu, A., Vanhoutte, P.M.: Toll-Like Receptor 4 Mutation Protects Obese Mice Against Endothelial Dysfunction by Decreasing NADPH Oxidase Isoforms 1 and 4. Arterioscler. Thromb. Vasc. Biol. 2013, 33, 777–784. [CrossRef] [PubMed]
204. Wang, J.H., Ling, D., Tu, L., van Wijngaarden, P., Dusting, G.J., Liu, G.S. Gene Therapy for Diabetic Retinopathy: Are We Ready to Make the Leap From Bench to Bedside? Pharmacol. Ther. 2017, 173, 1–18. [CrossRef] [PubMed]
205. Cai, T., Fassina, G., Morini, M., Aluigi, M.G., Masiello, L., Fontanini, G., D’Agostini, F., De Flora, S., Noonan, D.M., Albini, A.: N-Acetylcysteine Inhibits Endothelial Cell Invasion and Angiogenesis. Lab. Investig. 1999, 79, 1151–1159. [PubMed]
206. Trachootham, D., Alexandre, J., Huang, P. Targeting Cancer Cells by ROS-Mediated Mechanisms: A Radical Therapeutic Approach? Nat. Rev. Drug Discov. 2009, 8, 579–591. [CrossRef] [PubMed]
207. Myung, S.K., Ju, W., Cho, B., Oh, S.W., Park, S.M., Koo, B.K., Park, B.J.: Efficacy of Vitamin and Antioxidant Supplements in Prevention of Cardiovascular Disease: Systematic Review and Meta-Analysis of Randomised Controlled Trials. BMJ 2013, 346, f10. [CrossRef] [PubMed]
208. Rodiño-Janeiro, B.K., Paradela-Dobarro, B., Castiñeiras-Landeira, M.I., Raposeiras-Roubín, S., González-Juanatey, J.R., Alvarez, E. Current Status of NADPH Oxidase Research in Cardiovascular Pharmacology. Vasc. Health Risk Manag. 2013, 9, 401–428. [PubMed]
209. Heumuller, S., Wind, S., Barbosa-Sicard, E., Schmidt, H.H., Busse, R., Schroder, K., Brandes, R.P. Apocynin Is Not an Inhibitor of Vascular NADPH Oxidases but an Antioxidant. Hypertension 2008, 51, 211–217. [CrossRef] [PubMed]
210. Altenhofer, S., Radermacher, K.A., Kleikers, P.W., Wingler, K., Schmidt, H.H. Evolution of NADPH Oxidase Inhibitors: Selectivity and Mechanisms for Target Engagement. Antioxid. Redox Signal. 2015, 23, 406–427. [CrossRef] [PubMed]
211. Sharifpanah, F., De Silva, S., Bekhite, M.M., Hurtado-Oliveros, J., Preissner, K.T., Wartenberg, M., Sauer, H. Stimulation of Vasculogenesis and Leukopoiesis of Embryonic Stem Cells by Extracellular Transfer RNA and Ribosomal RNA. Free Radic. Biol. Med. 2015, 89, 1203–1217. [CrossRef] [PubMed]
212. Pi, X., Xie, L., Portbury, A.L., Kumar, S., Lockyer, P., Li, X., Patterson, C. NADPH Oxidase-Generated Reactive Oxygen Species Are Required for Stromal Cell-Derived Factor-1alpha-Stimulated Angiogenesis. Arterioscler. Thromb. Vasc. Biol. 2014, 34, 2023–2032. [CrossRef] [PubMed]
213. Huang, S., Tang, Y., Cai, X., Peng, X., Liu, X., Zhang, L., Xiang, Y., Wang, D., Wang, X., Pan, T. Celastrol Inhibits Vasculogenesis by Suppressing the VEGF-Induced Functional Activity of Bone Marrow-Derived Endothelial Progenitor Cells. Biochem. Biophys. Res. Commun. 2012, 423, 467–472. [CrossRef] [PubMed]
214. Li, Z., Li, J., Zhu, L., Zhang, Y., Zhang, J., Yao, L., Liang, D., Wang, L.: Celastrol Nanomicelles Attenuate Cytokine Secretion in Macrophages and Inhibit Macrophage-Induced Corneal Neovascularization in Rats. Int. J. Nanomed. 2016, 11, 6135–6148. [CrossRef] [PubMed]